この成分は何ですか?

이 원료는 탄소가 24-28개인 알킬사슬을 갖는 선형 알파올레핀의 혼합물이다.

成分一覧

成分辞典

C24-28 OLEFIN

定義

米国FDA 物質登録 · UNII 6P4501CWYB · 登録名 C24-28 OLEFIN · 混合物

出典: 米国FDA 物質識別番号（UNII）

Alkenes, C24-28 .alpha.-

化粧品での役割

肌を良い状態に保つ（CosIng 包括分類）SKIN CONDITIONING

安全性・規制情報

韓国の有害物質GHS分類なし · 既存化学物質

出典: 韓国有害物質GHS情報（環境公団）

詳しい資料 — 表示名・識別番号・物性・試験記録・文献

別名・識別情報

C24-28 OLEFININCIC24-28올레핀韓国の表示名（食薬処標準名）

CAS No.化学物質登録番号: 93924-11-9
EC No.EU化学物質目録番号: 300-203-7
DTXSID米国EPA化学物質番号: DTXSID1029835

測定された物性

性状: 液体
融点・凝固点: &amp, lt, ℃
初留点および沸点範囲: 64 ℃
引火点: -25 ℃
可燃性（固体、気体）: 引火性なし
蒸気圧: 24900 ㎩ (25℃)
溶解度: 47 ㎎/ℓ (20℃, pH: 6.5)
比重: 0.67
n-オクタノール/水分配係数（Kow）: 3.87 (log Pow, 20℃)
自然発火温度: 285 ℃ (102.7 kPa)
粘度: 0.441 mPa S

物質そのものを測定した値です。安全保健公団（KOSHA）の資料はSDS作成・確認の参考用で、原料商品の規格ではありません。

出典: 韓国安全保健公団 SDS

製品が実際に使っている用途

米国EPAにこの成分を届け出た製品2件の用途です。化粧品以外の製品も含まれるため、上の数行がこの成分の主な使い道といえます。

Processing aids not otherwise specified1
Softener and conditioner1

出典: 米国EPA CompTox

刺激・感作試験の記録

皮膚試験15件・眼試験6件の記録があります。

刺激が強いと分類5件中程度と分類2件低いと分類33件

試験ごとに結論が分かれています（最も多い結論の割合 13%）。この成分が刺激性だとは言い切れないということです。原料そのものを試験した記録で、完成品に含まれる濃度での刺激性とは異なります。

試験21件をすべて見る

Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to